Resistance to dopamine agonists in prolactinoma is correlated with reduction of dopamine D2 receptor long isoform mRNA levels

Reversal of Endogenous Dopamine Receptor Silencing in Pituitary Cells Augments Receptor-Mediated Apoptosis

(2010) Haneen Al-Azzawi et al.   ENDOCRINOLOGY

Immunohistochemical detection of dopamine D2 receptors in human pituitary adenomas.

(2010) Marek Pawlikowski   FOLIA HISTOCHEMICA ET CYTOBIOLOGICA

Expression of D2RmRNA isoforms and ERmRNA isoforms in prolactinomas: correlation with the response to bromocriptine and with tumor biological behavior

(2010) Zhe Bao Wu et al.   JOURNAL OF NEURO-ONCOLOGY

Acquired resistance to cabergoline: progression from initially responsive micro to macroprolactinoma

(2010) M. Alberiche Ruano et al.   Pituitary

Heregulin Regulates Prolactinoma Gene Expression

(2009) G. Vlotides et al.   CANCER RESEARCH

Invasive Giant Prolactinoma with Loss of Therapeutic Response to Cabergoline: Expression of Angiogenic Markers

(2009) María Susana Mallea-Gil et al.   ENDOCRINE PATHOLOGY

Characterization of resistance to the prolactin-lowering effects of cabergoline in macroprolactinomas: a study in 122 patients

(2009) Etienne Delgrange et al.   EUROPEAN JOURNAL OF ENDOCRINOLOGY

Expression Analysis of Dopamine Receptor Subtypes in Normal Human Pituitaries, Nonfunctioning Pituitary Adenomas and Somatotropinomas, and the Association between Dopamine and Somatostatin Receptors with Clinical Response to Octreotide-LAR in Acromegaly

(2009) Leonardo Vieira Neto et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Secondary resistance to cabergoline therapy in a macroprolactinoma: a case report and literature review

(2009) L. A. Behan et al.   Pituitary

Somatostatinergic ligands in dopamine-sensitive and -resistant prolactinomas

(2008) Alessandra Fusco et al.   EUROPEAN JOURNAL OF ENDOCRINOLOGY

Prospective Study of High-Dose Cabergoline Treatment of Prolactinomas in 150 Patients

(2008) Masami Ono et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Genes Differentially Expressed in Prolactinomas Responsive and Resistant to Dopamine Agonists

(2008) Vanessa Q. Passos et al.   NEUROENDOCRINOLOGY